Form 4: Elanco Director Gifts 60,000 Shares to Charitable Trust

Elanco Animal Health Inc. Director R. David Hoover reported a gift of 60,000 shares of common stock to a charitable trust, executed under a Rule 10b5-1 plan.

Summary

• R. David Hoover, a Director at Elanco Animal Health Inc. (ELAN), reported a transaction involving the company's common stock.
• On December 19, 2025, Hoover gifted 60,000 shares of Elanco common stock.
• The shares were gifted to a charitable trust, with a reported transaction price of $0 per share.
• This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-scheduled.
• Following the gift, Hoover directly beneficially owns 106,773 shares of common stock.
• Additionally, Hoover indirectly beneficially owns 150,000 shares through a revocable trust and 15,920 shares through the Suzanne A. Hoover Revocable Trust.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While it's a disposition of shares, it's a gift to charity and executed under a pre-planned Rule 10b5-1 plan, which suggests no immediate negative implications for the company's prospects. The director retains significant beneficial ownership.

Positives

• The transaction was a gift to a charitable trust, which can be viewed positively from a corporate social responsibility perspective.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and transparent disposition of shares, mitigating concerns about opportunistic insider selling.

Negatives

• A reduction in direct beneficial ownership by a director, even if a gift, represents a decrease in their direct equity stake, though overall beneficial ownership remains substantial.

Future Outlook

This filing, a Form 4, does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction report is specific to an individual director's shareholdings and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The direct beneficial ownership of a director has decreased by 60,000 shares, but the overall beneficial ownership remains substantial. The gift to a charitable trust may be viewed positively from a corporate social responsibility perspective.
• Employees, Customers, Suppliers, Creditors: This transaction is unlikely to have any direct impact on these stakeholders.

Key Dates

Recommendation

This Form 4 reports a director's gift of shares to a charitable trust under a pre-planned Rule 10b5-1 program. This is a routine insider transaction and does not indicate any change in the company's fundamental prospects or the director's confidence. The director retains significant beneficial ownership. Therefore, it provides no new information to warrant a change in investment recommendation.

Keywords

Elanco Animal Health, ELAN, R. David Hoover, Director, Insider Transaction, Form 4, Stock Gift, Charitable Trust, Rule 10b5-1, Beneficial Ownership